# Methylphenidate Extended-Release

NDC: 62542-250
Generic name: methylphenidate extended-release
Labeler / Manufacturer: Neos Therapeutics, LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: NDA AUTHORIZED GENERIC
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20260701

FDA application: NDA205489

## Active ingredients

- METHYLPHENIDATE: 17.3 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62542-250"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62542-250
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c2fec19b-6610-4ce0-8e60-f8218a11f62f